[HTML][HTML] Metformin as a therapeutic target in endometrial cancers
TY Lee, UE Martinez-Outschoorn, RJ Schilder… - Frontiers in …, 2018 - frontiersin.org
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
[PDF][PDF] Metformin as a Therapeutic Target in Endometrial Cancers
TY Lee, UE Martinez-Outschoorn, RJ Schilder, CH Kim… - academia.edu
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
[引用][C] Metformin as a Therapeutic Target in Endometrial Cancers
TY Lee, UE Martinez-Outschoorn, RJ Schilder… - Frontiers in …, 2018 - cir.nii.ac.jp
[HTML][HTML] Metformin as a Therapeutic Target in Endometrial Cancers
TY Lee, UE Martinez-Outschoorn, RJ Schilder… - Frontiers in …, 2018 - ncbi.nlm.nih.gov
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
Metformin as a Therapeutic Target in Endometrial Cancers.
TY Lee, UE Martinez-Outschoorn, RJ Schilder… - Frontiers in …, 2018 - europepmc.org
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
Metformin as a Therapeutic Target in Endometrial Cancers.
T Lee, UE Martinez-Outshoorn, RJ Schilder, CH Kim… - 2018 - jdc.jefferson.edu
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
[PDF][PDF] Metformin as a Therapeutic Target in Endometrial Cancers.
T Lee, UE Martinez-Outshoorn, RJ Schilder, CH Kim… - core.ac.uk
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
Metformin as a Therapeutic Target in Endometrial Cancers
TY Lee, UE Martinez-Outschoorn… - Frontiers in …, 2018 - pubmed.ncbi.nlm.nih.gov
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …